What is the ROCE (Return on Capital Employed) of Neogenomics this year?
The ROCE of Neogenomics is -0.1 undefined this year.
Neogenomics ROCE 2024
Neogenomics ROCE
-0.1
Ticker
NEO
ISIN
US64049M2098
WKN
120159
In 2024, Neogenomics's return on capital employed (ROCE) was -0.1, a -33.09% increase from the -0.15 ROCE in the previous year.
Neogenomics Aktienanalyse
What does Neogenomics do?
Neogenomics Inc. is a leading company in the field of personalized medicine, based in Fort Myers, Florida. It offers integrated diagnostics and pharmaceutical services for oncology and gene therapy, with a focus on providing accurate diagnosis for cancer patients. Neogenomics ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Neogenomics's Return on Capital Employed (ROCE)
Neogenomics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Neogenomics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Neogenomics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Neogenomics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Neogenomics stock
How has the ROCE (Return on Capital Employed) of Neogenomics developed compared to the previous year?
The ROCE of Neogenomics has increased by -33.09% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Neogenomics?
A high Return on Capital Employed (ROCE) indicates that Neogenomics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Neogenomics?
A low ROCE (Return on Capital Employed) can indicate that Neogenomics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Neogenomics impact the company?
An increase in the ROCE of Neogenomics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Neogenomics affect the company?
A decrease in ROCE of Neogenomics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Neogenomics?
Some factors that can affect Neogenomics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Neogenomics so important for investors?
The ROCE of Neogenomics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Neogenomics take to improve the ROCE?
To improve the ROCE, Neogenomics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Neogenomics pay?
Over the past 12 months, Neogenomics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Neogenomics is expected to pay a dividend of 0 USD.
What is the dividend yield of Neogenomics?
The current dividend yield of Neogenomics is .
When does Neogenomics pay dividends?
Neogenomics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Neogenomics?
Neogenomics paid dividends every year for the past 0 years.
What is the dividend of Neogenomics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Neogenomics located?
Neogenomics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Neogenomics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Neogenomics from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.
When did Neogenomics pay the last dividend?
The last dividend was paid out on 9/28/2024.
What was the dividend of Neogenomics in the year 2023?
In the year 2023, Neogenomics distributed 0 USD as dividends.
In which currency does Neogenomics pay out the dividend?
The dividends of Neogenomics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Neogenomics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Neogenomics
Our stock analysis for Neogenomics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neogenomics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
